Xtl Biopharmaceuticals (XTLB) Notes Payables (2024 - 2025)
Xtl Biopharmaceuticals (XTLB) recorded Notes Payables of $138,000 in the quarter ended Dec 31, 2025, unchanged from $138,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Notes Payables (2024 - 2025) Analysis & Trends
- Across earlier years, Notes Payables came in at $138,000 in the year ended Dec 31, 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 138,000.00 |
| Jun 30, 2025 | 86,000.00 |
| Dec 31, 2024 | 138,000.00 |
| Sep 30, 2024 | 168,000.00 |
API Access
Xtl Biopharmaceuticals Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();